Brief: Beijing Tong REN Tang Chinese Medicine Posts FY Profit Attributable Hk$556.1 Mln
March 24 (Reuters) - Beijing Tong Ren Tang Chinese Medicine
Co Ltd 3613.HK :
* FY PROFIT ATTRIBUTABLE HK$556.1 MILLION VERSUS HK$580.7
MILLION
* FY REVENUE HK$1.43 BILLION VERSUS HK$1.51 BILLION
* RECOMMENDED PAYMENT OF A FINAL DIVIDEND OF HK$0.23 PER
SHARE
* GROUP EXPECTS BUSINESS IN PRC, HONG KONG AND MACAO TO BE
GREATLY
IMPACTED BY CORONAVIRUS
* CORONAVIRUS MAY POTENTIALLY AFFECT GROUP'S FINANCIAL
PERFORMANCE
IN FIRST HALF OF 2020
Source text for Eikon: ID:nHKS1zt7WW
Further company coverage: 3613.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beijing Tong Ren Tang Chinese Medicine Co
See all newsBrief: Beijing Tong REN Tang Chinese Medicine Receives Certificate Of Registration Of Proprietary Chinese Medicine
Brief: Beijing Tong REN Tang Chinese Medicine Proposes Final Dividend HK$0.37 Per Share
Brief: Beijing Tong Ren Tang Chinese Medicine's Chairman & Exec Director Gu Hai Ou Retires
Brief: Beijing Tong Ren Tang Chinese Medicine Says Chen Fei Resigned As Exec Director
Brief: Beijing Tong REN Tang Chinese Medicine Says Strategic Cooperation Agreement With China Duty Free International